• Issue

    The Prostate: Volume 81, Issue 12

    797-920
    September 1, 2021
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Page: 797
  • First Published: 20 July 2021

ORIGINAL ARTICLES

Prostate cancer cells survive anti-androgen and mitochondrial metabolic inhibitors by modulating glycolysis and mitochondrial metabolic activities

Hirak S. Basu PhD,  Nathaniel Wilganowski BS,  Samantha Robertson BS,  James M. Reuben PhD,  Evan N. Cohen PhD,  Amado Zurita MD,  Sumankalai Ramachandran PhD,  Lian-Chun Xiao MS,  Mark Titus PhD,  George Wilding MD, 
  • Pages: 799-811
  • First Published: 25 June 2021

Therapeutic effects of β-caryophyllene on proliferative disorders and inflammation of the gerbil prostate

Nayara Fernanda da Costa Castro MD,  Fernanda Costa Jubilato MD,  Luiz Henrique Alves Guerra MD,  Fernanda Cristina Alcantara dos Santos MD, PhD,  Sebastião Roberto Taboga MD, PhD,  Patrícia Simone Leite Vilamaior MD, PhD, 
  • Pages: 812-824
  • First Published: 14 June 2021

Sociodemographic index and global trends in prostate cancer: 1990–2017

Bryn M. Launer BA,  Granville L. Lloyd MD, 
  • Pages: 825-831
  • First Published: 05 July 2021

Impact of median lobe on urinary function after robotic prostatectomy

Oscar Martinez MD,  Christopher Murphy DO,  Aya Bsatee OMS IV,  Ronney Abaza MD, FACS, 
  • Pages: 832-837
  • First Published: 14 June 2021
Open Access

Immune checkpoint B7-H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer

Caroline E. Nunes-Xavier PhD,  Wanja Kildal PhD,  Andreas Kleppe PhD,  Håvard E. Danielsen PhD,  Håkon Wæhre MD, PhD,  Roberto Llarena MD, PhD,  Gunhild M. Mælandsmo PhD,  Øystein Fodstad MD, PhD,  Rafael Pulido PhD,  José I. López MD, PhD, 
  • Pages: 838-848
  • First Published: 14 June 2021
Open Access

Twenty-year trends in prostate cancer stage and grade migration in a large contemporary german radical prostatectomy cohort

Christoph Würnschimmel MD,  Mykyta Kachanov MD,  Mike Wenzel MD, BSc,  Philipp Mandel MD,  Pierre I. Karakiewicz MD,  Tobias Maurer MD,  Thomas Steuber MD,  Derya Tilki MD,  Markus Graefen MD,  Lars Budäus MD, 
  • Pages: 849-856
  • First Published: 10 June 2021

Prospective study of diagnostic accuracy in the detection of high-grade prostate cancer in biopsy-naïve patients with clinical suspicion of prostate cancer who underwent the Select MDx test

Guillermo Lendínez-Cano MD,  Ana Victoria Ojeda-Claro MD, PhD,  Enrique Gómez-Gómez MD, PhD,  Pedro Morales Jimenez MD,  José Flores Martin MD,  Juan Francisco Dominguez MD,  Javier Amores MD,  Jose Manuel Cozar MD, PhD,  Jaime Bachiller MD,  Alvaro Juárez MD,  Ramón Linares MD,  Emilio Garcia Galisteo MD, PhD,  Jose Luis Alvarez Ossorio MD, PhD,  Maria José Requena Tapia MD, PhD,  Juan Moreno Jimenez MD,  Rafael Antonio Medina Lopez MD, PhD,  AEU-PIEM/2018/000 Investigators , 
  • Pages: 857-865
  • First Published: 29 June 2021

Percentage of Gleason pattern 4 and tumor volume predict adverse pathological stage and margin status at radical prostatectomy in grade Group 2 and grade Group 3 prostate cancers

Oleksii A. Iakymenko MD,  Isabella Lugo MPH,  Laurence M. Briski MD,  Ivan Nemov MD,  Sanoj Punnen MD,  Deukwoo Kwon PhD,  Alan Pollack MD, PhD,  Radka Stoyanova PhD,  Dipen J. Parekh MD,  Merce Jorda MD, PhD, MBA,  Mark L. Gonzalgo MD, PhD,  Oleksandr N. Kryvenko MD, 
  • Pages: 866-873
  • First Published: 29 June 2021
Open Access

Increasing rates of NCCN high and very high-risk prostate cancer versus number of prostate biopsy cores

Mike Wenzel MD, BSc,  Christoph Würnschimmel MD,  Claudia C. Ruvolo MD,  Luigi Nocera MD,  Zhe Tian MSc,  Fred Saad MD, PhD,  Alberto Briganti MD, PhD,  Derya Tilki MD, PhD,  Markus Graefen MD, PhD,  Luis A. Kluth MD, PhD,  Philipp Mandel MD, PhD,  Felix K.H. Chun MD, PhD,  Pierre I. Karakiewicz MD, PhD, 
  • Pages: 874-881
  • First Published: 29 June 2021
Open Access

SRSF-1 and microvessel density immunohistochemical analysis by semi-automated tissue microarray in prostate cancer patients with diabetes (DIAMOND study)

Giuseppe Broggi MD,  Arturo Lo Giudice MD,  Marina Di Mauro MD,  Maria Giovanna Asmundo MD,  Elisabetta Pricoco,  Eliana Piombino MD,  Rosario Caltabiano MD,  Giuseppe Morgia MD,  Giorgio Ivan Russo MD, PhD, 
  • Pages: 882-892
  • First Published: 01 July 2021

Long noncoding RNA GAS5 interacts and suppresses androgen receptor activity in prostate cancer cells

Shidong Lv PhD,  Xiaochun Pu PhD,  Mayao Luo MD,  Haoran Wen MD,  Zhuofan Xu MD,  Qiang Wei PhD,  Qiang Dang PhD, 
  • Pages: 893-901
  • First Published: 29 June 2021

Gonadotropin-releasing hormone antagonist associated with lower cardiovascular risk compared with gonadotropin-releasing hormone agonist in prostate cancer: A nationwide cohort and in vitro study

Dong-Yi Chen MD,  Po-Jung Su MD,  Lai-Chu See PhD,  Jia-Rou Liu MSc,  Cheng-Keng Chuang MD PhD,  See-Tong Pang MD PhD,  Chi-Nan Tseng MD,  Shao-Wei Chen MD PhD,  I-Chang Hsieh MD,  Pao-Hsien Chu MD,  Yung-Chang Lin MD,  Cheng-Lung Hsu MD, PhD,  John Wen-Cheng Chang MD,  Miao-Sui Lin MSc,  Jong-Hwei S. Pang PhD,  Ming-Jer Hsieh MD PhD,  Wen-Kuan Huang MD, PhD, 
  • Pages: 902-912
  • First Published: 01 July 2021

Machine learning algorithms can more efficiently predict biochemical recurrence after robot-assisted radical prostatectomy

Mithat Ekşi MD,  İsmail Evren MD,  Fatih Akkaş MD,  Yusuf Arıkan MD,  Osman Özdemir MD,  Deniz N. Özlü MD,  Ali Ayten MD,  Selcuk Sahin MD,  Volkan Tuğcu MD,  Ali İ. Taşçı MD, 
  • Pages: 913-920
  • First Published: 05 July 2021